Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
暂无分享,去创建一个
[1] R. Munday,et al. The relationship between the physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. , 1993, The Journal of endocrinology.
[2] M. Abdel‐Rahman,et al. Protection of B cells against the effect of alloxan. , 1992, Toxicology letters.
[3] R. Munday,et al. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. , 1991, Biochemical pharmacology.
[4] R. Munday,et al. Glutathione-mediated redox cycling of alloxan. Mechanisms of superoxide dismutase inhibition and of metal-catalyzed OH. formation. , 1989, Biochemical pharmacology.
[5] D. Eizirik,et al. Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. , 1988, Pharmacology & toxicology.
[6] R. Munday. Dialuric acid autoxidation. Effects of transition metals on the reaction rate and on the generation of "active oxygen" species. , 1988, Biochemical pharmacology.
[7] L. Oberley. Free radicals and diabetes. , 1988, Free radical biology & medicine.
[8] H. Hansson,et al. Relation between alloxan-induced plasma membrane dysfunction and inhibition of insulin secretion in pancreatic B-cells in vivo. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.
[9] R. Lorentzon,et al. Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro. , 1983, Endocrinology.
[10] W. Malaisse,et al. Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic B-cell against alloxan. , 1983, Biochimica et biophysica acta.
[11] D. Pipeleers,et al. Selective uptake of alloxan by pancreatic B-cells. , 1982, The Biochemical journal.
[12] W. Malaisse. Alloxan toxicity to the pancreatic B-cell. A new hypothesis. , 1982, Biochemical pharmacology.
[13] S. J. Cooperstein,et al. 15 – Action of Toxic Drugs on Islet Cells , 1981 .
[14] C. D. Barry,et al. Molecular requirements for recognition at glucoreceptor for insulin release. , 1979, Molecular pharmacology.
[15] S. Lenzen. Insulin secretion by isolated perfused rat and mouse pancreas. , 1979, The American journal of physiology.
[16] R. Melmed. Intermediate cells of the pancreas. An appraisal. , 1979, Gastroenterology.
[17] R. Lorentzon,et al. Stereological study of endoplasmic reticulum, golgi complex and secretory granules in the B-cells of normal and alloxan-treated mice , 1979, Virchows Archiv. B, Cell pathology including molecular pathology.
[18] P. Lacy,et al. Alloxan uptake by isolated rat islets of Langerhans. , 1978, Endocrinology.
[19] S. J. Cooperstein,et al. Effect of sulfhydryl-binding reagents on islet tissue permeability: protection and reversal by D-glucose and phlorizin. , 1978, The Journal of pharmacology and experimental therapeutics.
[20] L. Boquist. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[21] D. Fleita,et al. Reactions of Alloxan and Related Compounds , 1977 .
[22] T. Tomita,et al. The effect of alloxan on the permeability of isolated pancreatic islets to horseradish peroxidase , 1976, Virchows Archiv. B, Cell pathology.
[23] L. Orci,et al. Islet cell membrane alteration by diabetogenic drugs. , 1976, Laboratory investigation; a journal of technical methods and pathology.
[24] M. Arcangeli,et al. Studies of Alloxan Toxicity on the Beta Cell , 1975, Diabetes.
[25] S. J. Holt,et al. Intermediate cells of the pancreas. 3. Selective autophagy and destruction of beta-granules in intermediate cells of the rat pancreas induced by alloxan and streptozotocin. , 1973, Journal of cell science.
[26] L. M. Beidler,et al. Glucose and alloxan interactions in the pancreatic islets. , 1973, The American journal of physiology.
[27] G. Dryhurst,et al. Electrochemistry of Alloxan and Its N‐Methyl Derivatives in Aqueous Solution , 1971 .
[28] B. Volk,et al. Ultrastructural Pancreatic Beta-Cell Changes in Rabbits After Small and Large Doses of Alloxan , 1967, Diabetes.
[29] A. Lazarow,et al. EFFECT OF ALLOXAN ON PERMEABILITY OF PANCREATIC ISLET TISSUE IN VITRO. , 1964, The American journal of physiology.
[30] W. Carter,et al. Studies on Protection Against the Diabetogenic Effect of Alloxan by Glucose.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] Cardeza Af,et al. Electron microscopy of the pancreas in alloxan diabetes in the rat , 1958 .
[32] E. Neuzil,et al. Toxicité aiguë de la ninhydrine (hydrate d'indanetrione) pour la souris blanche. , 1957 .
[33] G. Bruckmann,et al. Preparation and properties of new derivatives of alloxan. , 1949, Journal of the American Chemical Society.
[34] K. Bernhard,et al. Beiträge zur Alloxan-Glucosurie , 1947 .
[35] E. Wertheimer,et al. Alloxan studies; the action of alloxan homologues and related compounds. , 1947, The Journal of biological chemistry.
[36] P. Hidy. Structural requirements for diabetogenic action in alloxan and related compounds. , 1946, The Journal of biological chemistry.
[37] B. Waisbren,et al. A Method for Consistent Induction of Chronic Hyperglycemia with Alloxan , 1945, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[38] E. Wertheimer,et al. Diabetogenic Action of Alloxan Derivatives , 1945, Nature.
[39] H. Biltz,et al. Über die Gewinnung von Dialursäuren und Uramilen , 1913 .
[40] H. Biltz. Alloxan-anhydrid und seine Methylderivate , 1912 .